KINETA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.487 USD | +1.84% |
|
-22.08% | -86.58% |
| 04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
| 03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 62.23 | 37.73 | 5.528 | - |
| Enterprise Value (EV) 1 | 62.23 | 37.73 | 5.528 | 5.528 |
| P/E ratio | -0.49 x | -2.84 x | -0.35 x | -0.36 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 6.93 x | - | - |
| EV / Revenue | - | 6.93 x | - | - |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 9,800 | 10,394 | 11,350 | - |
| Reference price 2 | 6.350 | 3.630 | 0.4870 | 0.4870 |
| Announcement Date | 3/31/23 | 3/21/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | 5.442 | - | - |
| EBITDA | - | - | - | - |
| EBIT 1 | - | -15.72 | -24.1 | -25.19 |
| Operating Margin | - | -288.92% | - | - |
| Earnings before Tax (EBT) 1 | - | -14.08 | -24.04 | -25.13 |
| Net income 1 | -63.41 | -14.1 | -24.04 | -25.13 |
| Net margin | - | -259.08% | - | - |
| EPS 2 | -12.87 | -1.280 | -1.410 | -1.350 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/31/23 | 3/21/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|
| Net sales 1 | 0.281 | 5.161 | - | - |
| EBITDA | - | - | - | - |
| EBIT 1 | -6.486 | -0.98 | -3.986 | -4.271 |
| Operating Margin | -2,308.19% | -18.99% | - | - |
| Earnings before Tax (EBT) 1 | - | - | -5.311 | -2.66 |
| Net income 1 | -6.451 | 0.386 | -5.38 | -2.654 |
| Net margin | -2,295.73% | 7.48% | - | - |
| EPS 2 | - | 0.0400 | -0.4600 | -0.1900 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 5/11/23 | 8/11/23 | 11/3/23 | 3/21/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 3/31/23 | 3/21/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -86.58% | 5.53M | |
| +8.29% | 114B | |
| +10.21% | 104B | |
| -11.90% | 22.41B | |
| +0.17% | 22.28B | |
| -5.48% | 19.07B | |
| -37.36% | 18B | |
| -5.17% | 17.89B | |
| +7.70% | 14.28B | |
| +37.65% | 12.55B |
- Stock Market
- Equities
- KA Stock
- Financials Kineta, Inc.
